For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

Oculeve, Inc.

USPTO Granted Patents = 33

EPO Patents = 6

Forward Citations = 727

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

James Donald Loudin (29 out of 45 patents)

Douglas Michael Ackermann (16 out of 34 patents)

Manfred Franke (14 out of 43 patents)

4. John L Wardle (12 out of 75 patents)

5. Janusz Kuzma (11 out of 20 patents)

6. Douglas Michael Ackermann, Jr (8 out of 37 patents)

7. Daniel N Hamilton (8 out of 22 patents)

8. Christopher William Stivers (5 out of 5 patents)

9. Jarren Armond Baldwin (4 out of 8 patents)

10. Amitava Gupta (3 out of 117 patents)

11. Daniel V Palanker (3 out of 82 patents)

12. John W Lai (3 out of 18 patents)

13. Scott Franklin Wetenkamp (3 out of 5 patents)

14. Marie Dvorak Christ (3 out of 8 patents)

15. Mark Jeffrey Holdbrook (3 out of 3 patents)

33 patents: Sort by Forward Citations

1. 10967173 - Nasal stimulation devices and methods for treating dry eye (2021-04-06),

2. 10940310 - Nasal stimulation for rhinitis, nasal congestion, and ocular allergies (2021-03-09),

3. 10918864 - Intranasal stimulation for treatment of meibomian gland disease and blepharitis (2021-02-16),

4. D907791 - Nasal stimulator body (2021-01-12),

5. 10835748 - Stimulation devices and methods (2020-11-17),

6. 10835738 - Nasal stimulation devices and methods (2020-11-17),

7. 10799696 - Polymer formulations for nasolacrimal stimulation (2020-10-13),

8. 10799695 - Nasal stimulation devices and methods (2020-10-13),

9. 10780273 - Stimulation devices and methods for treating dry eye (2020-09-22),

10. 10722713 - Stimulation patterns for treating dry eye (2020-07-28),

11. 10610695 - Implantable device for increasing tear production (2020-04-07),

12. 10610095 - Apparatus and method for dry eye forecast and treatment recommendation (2020-04-07),

13. 10537469 - Implant delivery devices, systems, and methods (2020-01-21),

14. 10426958 - Intranasal stimulation for enhanced release of ocular mucins and other tear proteins (2019-10-01),

15. 10328262 - Stimulation devices and methods (2019-06-25),

Oculeve, Inc. is a medical device company dedicated to developing innovative solutions for patients with dry eye disease. With a team of passionate researchers and engineers, we aim to revolutionize the way dry eye is managed. Our flagship product, the Oculeve Intranasal Tear Neurostimulator, stimulates the trigeminal nerve to promote tear production, providing long-lasting relief for individuals suffering from dry eye. Visit our website to learn more about our mission and the cutting-edge technology behind our products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

33 Patents

#133 in

#9,948 in

#19,556 in the World

San Francisco, CA, United States of America

Oculeve, Inc.

Forward Citations = 727

23 inventors:

James Donald Loudin (29 out of 45 patents)

Douglas Michael Ackermann (16 out of 34 patents)

Manfred Franke (14 out of 43 patents)

4. John L Wardle (12 out of 75 patents)

5. Janusz Kuzma (11 out of 20 patents)

Please report any incorrect information to support@idiyas.com

Loading…